摘要 |
The present disclosure relates to methods of using fatty acid amide hydrolase (FAAH) inhibitors to treat aspects of Parkinson's disease (PD), restless legs syndrome (RLS) and periodic limb movement disorder (PLMD), the use of FAAH inhibitors for the manufacture of medicaments for use in the treatment of PD, RLS and PLMD, as well as pharmaceutically acceptable compositions comprising FAAH inhibitors for use in the treatment of PD, RLS and PLMD. |
申请人 |
IRONWOOD PHARMACEUTICALS, INC.;PEARSON, JAMES, PHILIP;MILNE, G., TODD;JOHNSTON, THOMAS, HENRY;BROTCHIE, JONATHAN, MICHAEL;QUEST VENTURES LTD. |
发明人 |
PEARSON, JAMES, PHILIP;MILNE, G., TODD;JOHNSTON, THOMAS, HENRY;BROTCHIE, JONATHAN, MICHAEL |